Clinical Trials Browser

Suspended × selinexor × Plasma cell × Clear all

NCT04661137 2026-02-10

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma

Phase 2 Suspended

Multiple Myeloma